Skip to main content

Risk for Ovarian Cancer Increased for Women With Endometriosis

Medically reviewed by Carmen Pope, BPharm. Last updated on July 19, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, July 18, 2024 -- Women with endometriosis have an increased risk of ovarian cancer, with the highest risk seen for women with deep infiltrating endometriosis and/or ovarian endometriomas, according to a study published online July 17 in the Journal of the American Medical Association.

Mollie E. Barnard, Sc.D., from the University of Utah in Salt Lake City, and colleagues examined the associations of endometriosis subtypes with te incidence of ovarian cancer in a population-based cohort study using data from the Utah Population Database. A total of 78,893 women with endometriosis were matched in a 1:5 ratio to women without endometriosis.

The age at first endometriosis diagnosis was 36 years. Overall, 597 women had ovarian cancer. The researchers found that the risk for ovarian cancer was higher for women with versus those without endometriosis (adjusted hazard ratio, 4.20), and the risk for type I ovarian cancer was especially high (adjusted hazard ratio, 7.48). For all ovarian cancers, type I ovarian cancer, and type II ovarian cancer, the risk was highest for women with deep infiltrating endometriosis and/or ovarian endometriomas (adjusted hazard ratios, 0.66, 18.96, and 3.72, respectively).

"Studies that can better characterize the biology underlying these associations are urgently needed to guide improved ovarian cancer screening and prevention strategies among women with severe endometriosis, with or without other important ovarian cancer risk factors," the authors write.

One author received fees from Epi Excellence, and a second received fees from Epidemiologic Research & Methods.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

Read this next

American College of Obstetricians and Gynecologists, May 16-18

The annual meeting of the American College of Obstetricians and Gynecologists (ACOG) was held from May 16 to 18 in Minneapolis and was attended by more than 4,000...

Bilateral Salpingo-Oophorectomy Beneficial in BRCA1/2 Carriers With Personal History of Breast Cancer

TUESDAY, May 13, 2025 -- For carriers of pathogenic variants in BRCA1 and BRCA2 with a personal history of breast cancer, bilateral salpingo-oophorectomy (BSO) is beneficial...

Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer

MONDAY, May 12, 2025 -- The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.